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• Can be asymptomatic
• Can cause derangements in brain 
metabolism
• Ability to detect accurately is crucial
• Rapid, accurate identification is 
challenging
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2018: Nova glucometer was the first glucometer to be FDA 
approved for use in ICUs, including NICUs
Maine Medical Center recently adopted the Nova meter
…but point of care (POC) glucose tests have 
not been well studied in newborns...
Our study:
We explored whether the Nova glucometer (POC test) provides 
comparable measurements to the ABL837 Radiometer whole blood 
gas analyzer (Radiometer Medical ApS, Copenhagen,DK) (ABL 
test).
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Existing literature on NOVA in neonates: 
Nova meter 
can be used as 
diagnostic test 
Nova meter 
can be used as 
screening test 
Very poor 
accuracy of  
POC tests in 
neonates
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• Collected sample pairs
• Less than 10 minutes apart
• By heel stick
• 704 sample pairs
• September 2019 - March 2020
• Testing done only when clinically 
indicated (for symptoms or 
screening)
• 1st sample: POC glucose 
• 2nd sample: ABL glucose
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• Compared results between methods using Bland Altman plot
• Used ABL as the gold standard
• Calculated false positive rate (FPR) and false negative rate (FNR) 
for the POC test
• Chart review performed for all false negative POC values
• Hypoglycemia is <50 mg/dL
Analysis: 
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* Mean difference = 
-9.6 mg/dL
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• Average difference between POC and ABL 
values: -9.6 mg/dL
• Wide limits of agreement (-27.4- +8.1 mg/dL)
• FNR: 3.2% 
• FPR: 55%




et al.: 2021 Lambrew Research Retreat; Harold Osher Award for Excellence
Published by MaineHealth Knowledge Connection, 2021
12




• POC and ABL glucose tests are NOT equivalent 
• High FPR unnecessary interventions 
• FNR of 3%  risk missing true hypoglycemia
• Offset factor makes things worse 
• These findings have implications for the 
choice of glucose testing method in neonates 
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Changes in workflow:
• Using ABL test for all screenings in newborn 
nursery and L&D
• Increased use of ABL test in NICU
• Ongoing work to increase workflow efficiency
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Exploration of telemedicine for the delivery of Substance 
Use Disorder treatment during the COVID-19 Pandemic
Maine Medical Center, Portland, ME1; Maine Medical Center Research Institute, Portland, ME2
Rebecca Bell, BA1; Hannah Loeb, BA1; Michael Kohut, PhD2; Eric Anderson, PhD2; Kinna Thakarar, DO, MPH1; Rebecca Hutchinson, MD, MPH1
• The opioid epidemic has hit particularly hard in rural
states where resources for substance use disorder
(SUD) treatment options are particularly scarce.1-4
• During the COVID-19 pandemic, social distancing
policies required healthcare providers to turn to
telemedicine platforms for the majority of their
patient encounters.5
• Telemedicine, or the delivery of remote clinical
services using phone or video, has been proposed
as one possible solution to existing barriers to care
access in SUD.
• Preliminary studies have demonstrated promising
outcomes for various computer delivered therapy
models for individuals with alcohol or opioid use
disorder.6-8 However, much remains to be
understood about the feasibility and efficacy of
telemedicine in this particularly vulnerable
population.
• We interviewed a sample of people who inject drugs
(PWID), community partners (CP), and providers (Pr)
who live in and/or provide services in Maine.
• Thirty-six interviews were conducted between April 1,
2020 and February 28, 2021.
• Line by line coding was performed using MaxQDA by
RB, MK, and HL using inductive and deductive coding
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Results
• Telemedicine should be considered a viable
alternative to in-person care when patients and
providers agree it is appropriate.
• Telemedicine may offer an innovative solution to
many of the barriers posed by more traditional
models particularly in rural areas.
Conclusion
Discussion
• Substance use disorder treatment should not follow a “one-size-fits-all” model.
• Telemedicine offers a convenient alternative that may be useful under certain
circumstances and may alleviate some of the existing barriers to care access.
• Some participants expressed concerns regarding making adequate connections over a
virtual platform, while others felt well-supported during telemedicine visits.
• While telemedicine has the potential to reduce barriers to care for many, it is important to
recognize its capacity to exaggerate disparities amongst more marginalized populations.
Accommodating these difference will be critical in more widespread implementation of
telemedicine practices.
Click on poster for video presentation
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